The results demonstrated significantly greater engraftment of human CD45+ cells in mice inoculated with MOLM‐14/MUC1‐C versus MOLM‐14/vector cells (Figure 1B) with mean levels of AML engraftment of 31.1% and 1% respectively (n = 3; P = .02). Here, PTPRC is linked to acute myeloid leukemia.